Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy

Published:2013-08-23 Issue:6 Volume:61 Page:977-981
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Valteau-Couanet Dominique¹,Le Deley Marie-Cécile²,Bergeron Christophe³,Ducassou Stéphane⁴,Michon Jean⁵,Rubie Hervé⁶,Le Teuff Gwenael²,Coze Carole⁷,Plantaz Dominique⁸,Sirvent Nicolas⁹,Bouzy Jeanine²,Chastagner Pascal¹⁰,Hartmann Olivier¹

Affiliation:

1. Department of Pediatric and Adolescent Oncology; Institut Gustave Roussy; Villejuif; France

2. Biostatistics Unit; Institut Gustave Roussy; Villejuif; France

3. Department of Pediatrics; Centre Léon Bérard; Lyon; France

4. Onco-Hematology Department; CHU Pellegrin; Bordeaux; France

5. Department of Pediatrics; Institut Curie; Paris; France

6. Onco-Hematology Unit; CHU Purpan; Toulouse; France

7. Aix-Marseille Univ et APHM, Hôpital d'Enfants de La Timone, Service d'Hématologie-Oncologie Pédiatrique; Marseille; France

8. Pediatric Oncology Unit; CHU; Grenoble; France

9. Pediatric Oncology Unit; CHU; Montpellier; France

10. Pediatric Oncology Unit; CHU Nancy; Hopital d'enfants; Vandoeuvre; France

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference19 articles.

1. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol;Valteau-Couanet;J Clin Oncol,2005

2. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma;Kushner;J Clin Oncol,2004

3. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age;Kushner;J Clin Oncol,1994

4. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: A randomised controlled trial;Berthold;Lancet Oncol,2005

5. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of ¹³¹I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP;Pediatric Blood & Cancer;2023-08-13

2. Influence of cultivation practices on the metabolism of cytokinin and its correlation in rice production;Food and Energy Security;2023-07-24

3. The results of therapy in patients with high-risk neuroblastoma: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology;Pediatric Hematology/Oncology and Immunopathology;2023-05-12

4. Risk model based on minichromosome maintenance 2 using objective assessment for predicting survival of neuroblastoma;iScience;2023-02

5. Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience;Frontiers in Oncology;2022-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3